Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate
2006-11-17
2009-12-08
Stucker, Jeffrey (Department: 1649)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
C424S145100, C424S134100, C424S085100, C424S001410, C424S001490, C435S335000
Reexamination Certificate
active
07629311
ABSTRACT:
A method for delivering a biologic to a human with Alzheimer's-related dementia, comprising administering the biologic parenterally into the perispinal space of the human without direct intrathecal injection, and thereafter positioning the human's head below the horizontal. The method further includes delivering a TNF antagonist to the brain of a human for treating mild cognitive impairment, Alzheimer's related dementia, or vascular dementia, comprising administering the TNF antagonist golimumab parenterally into the perispinal space of the human without direct intrathecal injection, and thereafter positioning the human in a Trendelenburg position, for delivery of the golimumab to the brain via the human's vertebral venous system.
REFERENCES:
Tobinick and Gross, J Neuroinflam 5: 1-10, 2008.
W Sue T Griffin J Neuroinflamm 5: 1-3, 2008.
Dutt Aditi
Stucker Jeffrey
Sutton Ezra
Tobinick Edward Lewis
LandOfFree
Methods to facilitate transmission of large molecules across... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods to facilitate transmission of large molecules across..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods to facilitate transmission of large molecules across... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4069596